JP2007526336A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526336A5
JP2007526336A5 JP2007502061A JP2007502061A JP2007526336A5 JP 2007526336 A5 JP2007526336 A5 JP 2007526336A5 JP 2007502061 A JP2007502061 A JP 2007502061A JP 2007502061 A JP2007502061 A JP 2007502061A JP 2007526336 A5 JP2007526336 A5 JP 2007526336A5
Authority
JP
Japan
Prior art keywords
phenyl
trifluoromethyl
cyano
trifluoroethyl
cyclopropylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007502061A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526336A (ja
JP4805909B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/007245 external-priority patent/WO2005085185A1/en
Publication of JP2007526336A publication Critical patent/JP2007526336A/ja
Publication of JP2007526336A5 publication Critical patent/JP2007526336A5/ja
Application granted granted Critical
Publication of JP4805909B2 publication Critical patent/JP4805909B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007502061A 2004-03-03 2005-03-03 選択的アンドロゲン受容体モジュレーターとしてのアニリン誘導体 Expired - Lifetime JP4805909B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54979404P 2004-03-03 2004-03-03
US60/549,794 2004-03-03
PCT/US2005/007245 WO2005085185A1 (en) 2004-03-03 2005-03-03 Aniline derivatives as selective androgen receptor modulators

Publications (3)

Publication Number Publication Date
JP2007526336A JP2007526336A (ja) 2007-09-13
JP2007526336A5 true JP2007526336A5 (enExample) 2008-04-17
JP4805909B2 JP4805909B2 (ja) 2011-11-02

Family

ID=34919539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007502061A Expired - Lifetime JP4805909B2 (ja) 2004-03-03 2005-03-03 選択的アンドロゲン受容体モジュレーターとしてのアニリン誘導体

Country Status (5)

Country Link
US (2) US7514470B2 (enExample)
EP (1) EP1725522B1 (enExample)
JP (1) JP4805909B2 (enExample)
ES (1) ES2523017T3 (enExample)
WO (1) WO2005085185A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1654221A2 (en) * 2003-06-10 2006-05-10 Smithkline Beecham Corporation Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
JP2007505164A (ja) * 2003-06-10 2007-03-08 スミスクライン ビーチャム コーポレーション アンドロゲン、グルココルチコイド、ミネラルコルチコイドおよびプロゲステロン受容体のモジュレーターとしての1−アミノナフタレン類
WO2006113552A2 (en) * 2005-04-15 2006-10-26 Smithkline Beecham Corporation Cyanoarylamines
EP1954133A4 (en) * 2005-11-30 2010-11-24 Glaxosmithkline Llc PYRROLIDINANILINE
JP5102985B2 (ja) * 2006-07-18 2012-12-19 東ソ−・エフテック株式会社 含フッ素2級アミン化合物の製造方法
JP5205379B2 (ja) * 2006-08-09 2013-06-05 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー プロゲステロン受容体モジュレータとしてのピロリジノンアニリン
JP5204438B2 (ja) * 2007-07-31 2013-06-05 東ソ−・エフテック株式会社 含フッ素アミン化合物の製造方法
BRPI0907844B8 (pt) 2008-02-22 2021-05-25 Radius Health Inc compostos e método para modular um receptor de andrógeno, processos de preparação e composição farmacêutica dos mesmos e seus usos
US8268872B2 (en) 2008-02-22 2012-09-18 Radius Health, Inc. Selective androgen receptor modulators
MX2010010799A (es) * 2008-03-31 2011-03-25 Univ Columbia Metodo de diagnostico, prevencion y tratamiento de las enfermedades de la masa osea.
US8623909B2 (en) * 2008-05-09 2014-01-07 Aska Pharmaceutical Co., Ltd. Prophylactic/therapeutic agents for lifestyle-related diseases
AT509045B1 (de) 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H Verbindungen zur behandlung von asthma bronchiale
US8987319B2 (en) 2010-02-04 2015-03-24 Radius Health, Inc. Selective androgen receptor modulators
PT2568806T (pt) 2010-05-12 2016-08-05 Radius Health Inc Regimes terapêuticos
US8642632B2 (en) 2010-07-02 2014-02-04 Radius Health, Inc. Selective androgen receptor modulators
WO2012047617A1 (en) 2010-09-28 2012-04-12 Radius Health, Inc. Selective androgen receptor modulators
PL3122426T3 (pl) 2014-03-28 2023-05-15 Duke University Leczenie raka sutka z zastosowaniem selektywnych modulatorów receptora estrogenowego
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
RU2019117364A (ru) * 2014-10-16 2019-08-05 ДжиТиИкс, ИНК. Способы лечения урологических нарушений с применением селективных модуляторов андрогеновых рецепторов
SMT202200199T1 (it) 2016-06-22 2022-07-21 Ellipses Pharma Ltd Metodi di trattamento del cancro del seno ar+.
EP4374925A3 (en) 2017-01-05 2025-01-15 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
CN112566666A (zh) 2018-05-14 2021-03-26 努瓦申生物公司 靶向抗癌核激素受体的化合物
CN112423844B (zh) 2018-07-04 2024-08-13 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
CN119390714A (zh) 2019-02-12 2025-02-07 雷迪厄斯制药公司 方法和化合物
AU2020274113A1 (en) 2019-05-14 2021-11-11 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
WO2021097046A1 (en) 2019-11-13 2021-05-20 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
JP2024510792A (ja) 2021-03-23 2024-03-11 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物
JP2024516024A (ja) 2021-05-03 2024-04-11 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2272433A1 (en) * 1996-11-22 1998-05-28 James E. Audia N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide release and/or its synthesis
JP2001519769A (ja) 1996-11-22 2001-10-23 エラン・ファーマシューティカルズ・インコーポレイテッド N―(アリール/ヘテロアリール)アミノ酸誘導体、その医薬組成物および該化合物を用いたβ―アミロイドペプチドの放出および/またはその合成を阻害する方法
US6506782B1 (en) * 1998-02-27 2003-01-14 Athena Neurosciences, Inc. Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ES2243500T3 (es) * 2000-06-06 2005-12-01 Warner-Lambert Company Llc Ciclohexilaminas biciclicas y uso como antegonistas del receptor nmda.
MXPA03001632A (es) 2000-08-24 2004-09-10 Univ Tennessee Res Corp Moduladores receptores de androgeno selectivos y metodos para usar los mismos.
CN1176905C (zh) * 2002-03-22 2004-11-24 清华大学 甘氨酸乙酯邻苯二腈及其合成方法与应用
EP1654221A2 (en) * 2003-06-10 2006-05-10 Smithkline Beecham Corporation Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators

Similar Documents

Publication Publication Date Title
JP2007526336A5 (enExample)
JP2006526630A5 (enExample)
JP2007505164A5 (enExample)
CA2614529A1 (en) Pyridazinone derivatives as thyroid hormone receptor agonists
RU2005137175A (ru) Производные сложного эфира и амида 2-цианопропановой кислоты и способы их применения
JP2007502264A5 (enExample)
JP2010526025A5 (enExample)
JP2009528296A5 (enExample)
JP2008501800A5 (enExample)
JP2019537605A5 (enExample)
JP2004525179A5 (enExample)
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
RS52816B (sr) Derivati propionamida koji se koriste kao modulatori androgenih receptora
JP2009541489A5 (enExample)
JP2003517035A5 (enExample)
JP2007500245A5 (enExample)
JP2005522438A5 (enExample)
JP2007533722A5 (enExample)
JP2004533450A5 (enExample)
JP2010522710A5 (enExample)
RU2009110243A (ru) Амиды как ингибиторы сфингомиелина
JP2006516280A5 (enExample)
JP2017509694A5 (enExample)
JP2003505362A5 (enExample)
JP2004518658A5 (enExample)